Evidence map›Paper›PMID 39969200›Full record

ArticleBlood advances2025

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.

Reid Shaw, James J Yoon, Hannah Johnston, Marta B Davidson, Alexa J Siddon, Rory M Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil G Iyer and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Reid ShawSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
James J YoonLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Hannah JohnstonSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Marta B DavidsonDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0001-6978-1368
Alexa J SiddonDepartments of Laboratory Medicine and Pathology, Yale School of Medicine, New Haven, CT.
Rory M ShallisHematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.ORCID 0000-0002-8542-2944
Evan C ChenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Madelyn BurkartAtrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.
Timothy S OhDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Sunil G IyerDivision of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-2507-9347
Ellen MadarangDepartment of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Chandrasekar MuthiahDepartment of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI.
Joshua KassnerDivision of Hematology and Medical Oncology, Weill Department of Medicine, Cornell University, Ithaca, NY.
Raajit K RampalLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Guru Subramanian Guru MurthyDivision of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI.
Terrence BradleyDepartment of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Yasmin AbazaDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0002-9156-7912
Jacqueline S GarciaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-2118-6302
Vikas GuptaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-1419-8607
Kristen M PettitDivision of Hematology and Medical Oncology, Department of Internal Medicine, University of Michigan Medical School, Michigan Medicine, Ann Arbor, MI.
Olatoyosi OdenikeSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Anand A PatelSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.ORCID 0000-0002-0296-8686

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39969200
PMCPMC12144506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.